Your browser doesn't support javascript.
loading
SUPREME-HN: a retrospective biomarker study assessing the prognostic value of PD-L1 expression in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Pai, Sara I; Cohen, Ezra E W; Lin, Derrick; Fountzilas, George; Kim, Edward S; Mehlhorn, Holger; Baste, Neus; Clayburgh, Daniel; Lipworth, Loren; Resteghini, Carlo; Shara, Nawar; Fujii, Takashi; Zhang, Jun; Stokes, Michael; Wang, Huifen; Twumasi-Ankrah, Philip; Wildsmith, Sophie; Khaliq, Asud; Melillo, Giovanni; Shire, Norah.
Afiliación
  • Pai SI; Massachusetts General Hospital Cancer Center, Harvard Medical School, 55 Fruit Street, GRJ 9-904G, Boston, MA, 02114, USA. sara.pai@mgh.harvard.edu.
  • Cohen EEW; UC San Diego Health System, Moores Cancer Center, La Jolla, CA, USA.
  • Lin D; Massachusetts General Hospital Cancer Center, Harvard Medical School, 55 Fruit Street, GRJ 9-904G, Boston, MA, 02114, USA.
  • Fountzilas G; Massachusetts Eye and Ear, Boston, MA, USA.
  • Kim ES; Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Mehlhorn H; Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Baste N; Universitaetsklinikum Leipzig, Klinik und Poliklinik fur HNO-Heilkunde, Leipzig, Germany.
  • Clayburgh D; Department of Oncology, Hospital Universitari Vall d'Hebron & Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Lipworth L; Oregon Health & Science University, Portland, OR, USA.
  • Resteghini C; Vanderbilt University Medical Center, Nashville, TN, USA.
  • Shara N; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Fujii T; MedStar Health Research Institute, Hyattsville, MD, USA.
  • Zhang J; Osaka International Cancer Institute, Osaka, Japan.
  • Stokes M; Baylor College of Medicine, Houston, TX, USA.
  • Wang H; Evidera, Lexington, MA, USA.
  • Twumasi-Ankrah P; AstraZeneca, Gaithersburg, MD, USA.
  • Wildsmith S; AstraZeneca, Gaithersburg, MD, USA.
  • Khaliq A; AstraZeneca, Cambridge, UK.
  • Melillo G; AstraZeneca, Gaithersburg, MD, USA.
  • Shire N; AstraZeneca, Gaithersburg, MD, USA.
J Transl Med ; 17(1): 429, 2019 12 26.
Article en En | MEDLINE | ID: mdl-31878938
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Antígeno B7-H1 / Carcinoma de Células Escamosas de Cabeza y Cuello / Recurrencia Local de Neoplasia Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Transl Med Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Antígeno B7-H1 / Carcinoma de Células Escamosas de Cabeza y Cuello / Recurrencia Local de Neoplasia Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Transl Med Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos